View Author
cancer screening colonoscopy colorectal colorectal cancer model incidence cohort stage population study adenomas sensitivity trial women mortality strategy health result trend cost-effectiveness death colonoscopy screening adenoma treatment analysis estimate colorectal cancer screening risk factors factor table group colon patient van ballegooijen m interval endoscopy control surveillance life-year report diagnosis intervention duration effect state disease change ctc screening individual crc screening threshold costs phase number hypothesis research death rates polyps breast distribution impact lansdorp-vogelaar difference parameter screen increase uniform program referral 15 cancers assumption policy cause crc incidence threshold miscan-colon history simulation life expectancy ballegooijen
10 Most Recent Publications
|
Multicohort models in cost-effectiveness analysis: Why aggregating estimates over multiple cohorts can hide useful information
(Article)
O'Mahony, J.F. Rosmalen, J.M. van Zauber, A.G. Ballegooijen, M. van |
2013-04-01
|
|
Response
(Article)
Knudsen, A.B. Lansdorp-Vogelaar, I. Rutter, C.M. Savarino, J.E. Ballegooijen, M. van Kuntz, K.M. Zauber, A.G. |
2010-11-03
|
|
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population
(Article)
Knudsen, A.B. Lansdorp-Vogelaar, I. Rutter, C.M. Savarino, J.E. Ballegooijen, M. van Kuntz, K.M. Zauber, A.G. |
2010-08-18
|
|
Changes in risk factors and increases in screening contribute to the decline in colorectal cancer mortality, 1975 to 2000
(Article)
Zauber, A.G. Lansdorp-Vogelaar, I. |
2010-08-17
|
|
Simulation of colorectal cancer screening: What we do and do not know and does it matter
(Article)
Ballegooijen, M. van Boer, R. Zauber, A.G. |
2010-08-01
|
|
Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
(Article)
Edwards, B.K. Ward, E. Ballegooijen, M. van Goede, S.L. Ries, L.A.G. Kohler, B.A. Eheman, C. Zauber, A.G. Anderson, R.N. Jemal, A. Schymura, M.J. Lansdorp-Vogelaar, I. Seeff, L.C. |
2010-02-01
|
|
Response to the letter to the editor by Hassan et al.: The diminutive lesion versus the advanced adenoma: Which is the real target of CT colonography screening?
(Article)
Lansdorp-Vogelaar, I. Ballegooijen, M. van Zauber, A.G. Boer, R. Wilschut, J.A. Habbema, J.D.F. |
2009-09-01
|
|
Individualizing colonoscopy screening by sex and race
(Article)
Lansdorp-Vogelaar, I. Ballegooijen, M. van Zauber, A.G. Boer, R. Wilschut, J.A. Winawer, S.J. Habbema, J.D.F. |
2009-07-01
|
|
A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials
(Article)
Lansdorp-Vogelaar, I. Ballegooijen, M. van Boer, R. Zauber, A.G. Habbema, J.D.F. |
2009-06-26
|
|
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach
(Article)
Lansdorp-Vogelaar, I. Ballegooijen, M. van Zauber, A.G. Boer, R. Wilschut, J.A. Habbema, J.D.F. |
2009-03-01
|
